Sirio Pharma Co., Ltd.
SZSE:300791.SZ
30.67 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 282.018 | 240.288 | 212.286 | 231.834 | 257.366 | 142.525 | 203.225 | 104.3 | 703.726 | 56.267 | 61.449 | 54.548 | 45.333 |
| Depreciation & Amortization
| 239.267 | 263.04 | 131.742 | 104.062 | 79.716 | 71.58 | 54.961 | 48.13 | 32.334 | 28.972 | 26.583 | 19.119 | 15.612 |
| Deferred Income Tax
| 0 | -13.338 | 12.855 | 14.779 | 18.047 | -4.461 | -3.035 | -12.762 | -11.838 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | -3.987 | 21.3 | 7.768 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -107.638 | -202.755 | 23.508 | -28.731 | -23.634 | 3.71 | -103.405 | -134.768 | 42.858 | -17.202 | -10.454 | 36.746 | -34.984 |
| Accounts Receivables
| -57.38 | -125.214 | -75.051 | -75.337 | -93.812 | -65.643 | -50.855 | -28.675 | -55.17 | 0 | 0 | 0 | 0 |
| Inventory
| -5.716 | -59.303 | 3.56 | 22.892 | -65.04 | 18.819 | -43.974 | -38.854 | -26.618 | -13.271 | 20.705 | -22.199 | -21.9 |
| Accounts Payables
| 0 | 6.571 | 82.145 | 8.934 | 117.171 | 54.996 | -5.541 | -54.476 | 136.484 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -44.543 | -24.809 | 12.855 | 14.779 | 18.047 | -4.461 | -59.431 | -95.913 | 69.476 | -3.931 | -31.159 | 58.945 | -13.084 |
| Other Non Cash Items
| 153.324 | 98.847 | 77.324 | 34.212 | 6.125 | 13.789 | 28.675 | 31.69 | -877.182 | 38.677 | 13.358 | 12.091 | 9.285 |
| Operating Cash Flow
| 566.972 | 386.082 | 444.86 | 341.377 | 319.573 | 231.605 | 183.456 | 49.352 | -98.264 | 106.714 | 90.936 | 122.504 | 35.246 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -412.132 | -451.705 | -293.693 | -524.684 | -223.143 | -166.899 | -239.324 | -159.823 | -72.652 | -160.415 | -68.836 | -62.124 | -65.758 |
| Acquisitions Net
| 0 | -707.543 | 0 | 0.454 | 0.019 | 0.187 | 0.03 | 230.851 | 499.679 | 0 | 0.004 | 0 | 0 |
| Purchases Of Investments
| -399 | -682.565 | -2,159.443 | -1,560.702 | -620 | -446.1 | 0 | 0 | 0 | 0 | -7.108 | -11.59 | 0 |
| Sales Maturities Of Investments
| 503.833 | 579.396 | 2,863.41 | 1,349.452 | 446.946 | 16.144 | 0.618 | 0 | 0 | 0 | 0.012 | 0 | 0 |
| Other Investing Activites
| -20.685 | 104.553 | -126.369 | 0 | 1.2 | -1.2 | 0.03 | 0.222 | -45.985 | 73.755 | -1.277 | 0.018 | 0.001 |
| Investing Cash Flow
| -327.983 | -1,157.864 | 283.905 | -735.479 | -394.978 | -597.867 | -238.676 | 71.25 | 381.043 | -86.66 | -77.209 | -73.695 | -65.758 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 122.855 | 97.067 | 0.034 | 984.222 | -64.828 | -321.101 | 55.773 | -26.653 | 145.142 | 98.24 | 38.8 | 1.067 | 38.223 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -30.997 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -219.628 | -63.174 | -76.088 | -72.533 | -25.861 | -14.271 | -44.255 | -225.302 | -266.349 | -138.116 | -57.499 | -10.995 | -19.87 |
| Other Financing Activities
| -34.072 | -125.042 | -1.843 | -5.576 | -2.223 | 1,016.248 | 1.001 | 153.371 | -123.278 | 26.471 | -1.304 | -0.816 | -1.521 |
| Financing Cash Flow
| -130.845 | -91.148 | -77.897 | 906.113 | -92.912 | 680.876 | 12.519 | -98.584 | -244.486 | -13.405 | -20.003 | -10.744 | 16.832 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 2.498 | -4.59 | 29.855 | -11.27 | -12.163 | 2.185 | 3.053 | -10.714 | 8.676 | 1.266 | 0.151 | -2.309 | -0.658 |
| Net Change In Cash
| 110.642 | -867.52 | 680.723 | 500.741 | -180.48 | 316.798 | -39.648 | 11.304 | 46.969 | 7.915 | -6.125 | 35.756 | -14.338 |
| Cash At End Of Period
| 632.578 | 521.936 | 1,389.456 | 708.733 | 207.992 | 388.471 | 71.673 | 111.322 | 100.018 | 53.048 | 45.133 | 51.259 | 15.503 |